Vital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend

Bulletin Express

08/14

Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:

• Approval of the consolidated interim results for the six months ended 30 June 2026. • Deliberation on the declaration and amount of an interim dividend, if any.

The meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.

The company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1184550663"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184550663\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184550663?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184550663","market":"us","top_or_hot":-1,"title":"Vital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend","media":"Bulletin Express","content":"<p>Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:</p>\n<p>• Approval of the consolidated interim results for the six months ended 30 June 2026.  \n• Deliberation on the declaration and amount of an interim dividend, if any.</p>\n<p>The meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.</p>\n<p>The company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVital Innovations Schedules 26 Aug 2026 Board Meeting to Approve 1H26 Interim Results and Consider Dividend\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-14 17:27</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:</p>\n<p>• Approval of the consolidated interim results for the six months ended 30 June 2026.  \n• Deliberation on the declaration and amount of an interim dividend, if any.</p>\n<p>The meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.</p>\n<p>The company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06133","symbol_name":"維太創科","start_time":0,"source_url":"","article_id":"1184550663","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184550663","pubTimestamp":1786699659,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include: • Approval of the consolidated interim results for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06133":"维太创科"},"translate_title":"Vital Innovations 计划于 2026 年 8 月 26 日召开董事会会议，批准 26 年上半年中期业绩并考虑股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06133":1},"content_text":"Vital Innovations Holdings Limited announced that its board of directors will convene on Wednesday, 26 August 2026. Key agenda items include:\n• Approval of the consolidated interim results for the six months ended 30 June 2026.  \n• Deliberation on the declaration and amount of an interim dividend, if any.\nThe meeting will be chaired by Ms. Rong Xiuli. As of 14 August 2026, the board comprises four executive directors—Ms. Rong Xiuli, Mr. Rong Shengli, Mr. Yin Xuquan and Mr. Wong Ho Chun—and three independent non-executive directors—Mr. Han Xiaojing, Mr. Wong Pong Chun James and Mr. Leung Man Fai.\nThe company is incorporated in the Cayman Islands and its shares trade on the Stock Exchange of Hong Kong under stock code 06133.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}